Luxor Capital Group, LP Harrow Health, Inc. Transaction History
Luxor Capital Group, LP
- $1.93 Billion
- Q3 2025
A detailed history of Luxor Capital Group, LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Luxor Capital Group, LP holds 307,337 shares of HROW stock, worth $12.5 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
307,337Holding current value
$12.5 Million% of portfolio
0.75%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
218Shares Held
21.7MCall Options Held
998KPut Options Held
593K-
Opaleye Management Inc. Boston, MA3.91MShares$159 Million30.67% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$87.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$76.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.86MShares$75.6 Million9.42% of portfolio
-
State Street Corp Boston, MA794KShares$32.4 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.1B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...